Skip to the page

Data / Drug companies / Zhejiang Xianju Pharmaceutical Co., Ltd.

Zhejiang Xianju Pharmaceutical Co., Ltd.: 38 products in the FDA NDC directory, labeler code 60722

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Zhejiang Xianju Pharmaceutical Co., Ltd. (labeler code 60722) lists 38 products in the FDA National Drug Code Directory, covering 1 finished drug by generic name. By type: 37 bulk ingredients, 1 prescription drugs. Its main marketing category is bulk ingredients. The newest product started marketing on June 3, 2026.

The request: Watch Zhejiang Xianju Pharmaceutical Co., Ltd. (FDA labeler code 60722): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
60722
Products in commercial distribution
38
Packages
83
Finished drugs by generic name
1
Prescription products
1
Over the counter products
0
Controlled substance products
Schedule III 3, Schedule IV 1
Flagged as original packager
1 of 1 products that carry the flag
Started marketing in the last 12 months
2
Earliest marketing start
January 6, 2016
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Bulk ingredients3797.4%
Generic drugs (ANDA)12.6%

Products by type

TypeProductsShare
Bulk ingredients3797.4%
Prescription drugs12.6%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Prednisolone17

Dosage forms

Dosage formProductsShare
Powder3797.4%
Tablet12.6%

Pharmacologic classes

FDA established pharmacologic classes of its products.

ClassProducts
Corticosteroid1

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Betamethasone60722-3027PowderBulk ingredientsJune 3, 2026
Estradiol cypionate60722-3026PowderBulk ingredientsNovember 13, 2025
Tiotropium bromide monohydrate60722-1012PowderBulk ingredientsSeptember 25, 2025
Melengestrol acetate60722-1011PowderBulk ingredientsSeptember 25, 2025
Levonorgestrel60722-3025PowderBulk ingredientsApril 21, 2025
Clascoterone60722-3024PowderBulk ingredientsApril 21, 2025
Estradiol benzoate60722-3023PowderBulk ingredientsApril 21, 2025
Dydrogesterone60722-1010PowderBulk ingredientsApril 10, 2025
Prednisolone60722-5011TabletGeneric drugs (ANDA)September 1, 2024
Estradiol valerate60722-3022PowderBulk ingredientsDecember 28, 2023
Mometasone furoate60722-3021PowderBulk ingredientsAugust 31, 2023
Testosterone60722-3020PowderBulk ingredientsJuly 26, 2023
Megestrol acetate60722-1009PowderBulk ingredientsJune 6, 2023
Betamethasone valerate60722-3018PowderBulk ingredientsOctober 11, 2022
Ethinylestradiol60722-3017PowderBulk ingredientsOctober 11, 2022
Testosterone cypionate60722-3016PowderBulk ingredientsJuly 22, 2022
Brexanolone60722-3015PowderBulk ingredientsJuly 14, 2022
Dexamethasone sodium phosphate60722-3014PowderBulk ingredientsDecember 14, 2021
Dexamethasone60722-3013PowderBulk ingredientsDecember 14, 2021
Triamcinolone acetonide60722-3012PowderBulk ingredientsDecember 14, 2021
Eltanolone60722-3011PowderBulk ingredientsJuly 24, 2021
Progesterone60722-3010PowderBulk ingredientsNovember 25, 2020
Testosterone tridecanoate60722-3009PowderBulk ingredientsNovember 5, 2020
Testosterone dodecanoate60722-3008PowderBulk ingredientsNovember 5, 2020
Testosterone undecanoate60722-3007PowderBulk ingredientsNovember 5, 2020

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.